Medical Program: Understanding Treat-to-Target Strategy in the Management of PsA

Understanding Treat-to-Target Strategy in the Management of PsA

Understanding Treat-to-Target Strategy in the Management of PsA
RestartResume
Adopting a treat-to-target approach can significantly improve disease activity in your psoriatic arthritis patients. Have you been hitting the target?
  • Overview

    What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

     

Facebook Comments

Sign-up for the Rheumatology Academy newsletters.
Comprehensive Rheumatology Education.

Better education for a better you.

* Required
Optional
Register

Join Rheumatology Academy's community of learners. Registration is free and easy.

Register Now